Annexon reports pipeline updates and $55.3 million loss
Annexon (NASDAQ:ANNX) reported second-quarter 2026 financial results and clinical pipeline updates, including a net loss of $55.3 million, or $0.28 per share, for the quarter ended June 30, 2026.











